- Fujimoto K*. Metagenome data-based phage therapy for intestinal bacteria-mediated diseases. Biosci Microbiota Food Health. 42, 8-12 (2023) (*corresponding author)
- Fujimoto K, Uematsu S. Phage therapy for Clostridioides difficile infection. Front Immunol. 13, 1057892 (2022)
- Fujimoto K, Miyaoka D, Uematsu S. Characterization of the human gut virome in metabolic and autoimmune diseases. Inflamm Regen. 42, 32 (2022)
- Fujimoto K, Uematsu S. Vaccine therapy for dysbiosis-related diseases. World J Gastroenterol. 26, 2758-2767 (2020)
- Fujimoto K, Uematsu S. Development of prime-boost-type next-generation mucosal vaccines. Int Immunol. 32, 597-603 (2020)
- Uematsu S, Fujimoto K. The innate immune system in the intestine. Microbiol Immunol. 54, 645-657 (2010)